TREATMENT OF COAGULOPATIA WITH HYPERFIBRINOLYSIS

摘要

The invention relates to the use of thrombomodulin analogues for the manufacture of a medicament for the treatment of coagulopathies with hyperfibrinolysis, such as hemophilia. These therapeutically effective doses of thrombomodulin demonstrate an antifibrinolytic effect. New protein modifications are described along with methods for identifying them.